Accelerated hypofractionated chemoradiation for locally advanced head and neck cancer during COVID 19 pandemic: A tertiary care experience

CONCLUSION: During a pandemic crisis with limited manpower & technical resources accelerated hypofractionated radiotherapy with concurrent chemotherapy can be considered a feasible therapeutic option for HNSCC which can significantly reduce the overall Treatment Time (OTT) with comparable local control and manageable toxicities.PMID:38554353 | DOI:10.4103/jcrt.jcrt_1747_22

Source: Cell Research - March 30, 2024 Category: Cytology Authors: Sumit Agarwal Isha Jaiswal Uday P Shahi Abhijit Mandal Lalit M Aggarwal Ankita Singh Anil Jaiswal Nandlal Yadawa Source Type: research